Company news and developments, with original sources and dates.
Updated from source·Oct 18, 2026, 08:31 UTC
On September 16, 2026, Shanghai-based Anew Labs, an AI drug discovery platform spun off from ByteDance, raised USD 290 million in its first external round co-led by HSG Sequoia China, IDG Capital, Hillhouse Ventures and 5Y Capital, at a USD 1.5 billion valuation.